Acetylon Pharmaceuticals' Series B Round

Acetylon Pharmaceuticals raised a round of funding on February 22, 2011.

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…

Articles about Acetylon Pharmaceuticals' Series B Round: